{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017038","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.196614+00:00","generated_at":"2026-06-15T01:18:45.220588+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ensysce closes $7M public offering of common stock and warrants","bullets":["Offered 1,800,876 shares (or pre-funded warrants) plus Series A-1/A-2 warrants at $3.887 per unit.","Gross proceeds ~$7M; net proceeds for clinical development and working capital.","H.C. Wainwright acted as exclusive placement agent for the offering.","Amended 210,085 existing warrants from $16.80-$187.20 to $3.637 per share at $0.125 per amended warrant."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017038","json":"https://secwatch.observer/filing/0001493152-23-017038.json","markdown":"https://secwatch.observer/filing/0001493152-23-017038.md","text":"https://secwatch.observer/filing/0001493152-23-017038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/0001493152-23-017038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T01:18:45.220588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"76b2474c672242c695d2fafdc8baad07b2a383df","claim":"Ensysce Biosciences, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $7.0 million (effective 2023-05-10).","evidence_excerpt":"In connection with the offering of the Shares, we entered into a definitive Securities Purchase Agreement (the “ Purchase Agreement ”) with certain institutional investors (the “ Purchasers ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223017038/0001493152-23-017038-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"approximately $7.0 million"},{"label":"Effective","value":"2023-05-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}